| Revenue | DKK 1,7M | +101% |
| EBITDA | DKK 1M | +617% |
| Net profit | DKK 778K | +643% |
| Total assets | DKK 13,8M | +2% |
| Equity | DKK 11,6M | +7% |
| Employees | 9 | — |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 14.938 | 1.485 | 1.303 | 1.779 | 839 | 1.683 |
| Staff expenses | -4.078 | -3.952 | -0 | -4.300 | -4.033 | -3.732 |
| EBITDA | 2.276 | 906 | 541 | 917 | 140 | 1.007 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 2.276 | 906 | 541 | 917 | 140 | 1.007 |
| Net financials | -16 | 47 | 33 | -2 | -8 | -17 |
| Profit before tax | 2.261 | 957 | 763 | 1.191 | 132 | 991 |
| Tax | 562 | -0 | -0 | -0 | 27 | 213 |
| Net profit | 1.699 | 953 | 575 | 915 | 105 | 778 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|
| Total assets | 17.543 | 18.724 | 19.317 | 21.417 | 13.547 | 13.777 |
| Equity | 8.263 | 9.216 | 9.791 | 10.706 | 10.811 | 11.589 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7.154 | 7.818 | 7.881 | 9.043 | 2.068 | 1.726 |
| Total debt | 7.154 | 7.818 | 7.881 | 9.043 | 2.068 | 1.726 |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HO Management | Management | 1982 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2009 | — | — | |
| Board of Directors | 1982 | — | — | |
| Chairman | 1982 | — | — | |
| Board of Directors | 2004 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PHARMA-TRADE A/S | Company | 100.0% | 100.0% | 2009 |
| Person | Role here | Other companies |
|---|---|---|
| Henrik Overgaard | Management | 0 companies |
| Jan Overgaard | Board of Directors | 0 companies |
| Niels Ebbe Valdal | Board of Directors | 0 companies |
| Ib Preben Overgaard | Chairman | 0 companies |
| Malene Charlotte Overgaard | Board of Directors | 0 companies |